Our group has reported high levels of IGFBP5 in lung tissues and primary pulmonary fibroblasts (pFBs) of SSc-PF and IPF patients as well as in dermal fibroblasts of SSc patients [10,11,12]. Here, IGFBP5 is linked to systemic sclerosis.